In Vivo Lead Gen Campaign

What is digital pathology?

Advanced technology now makes it possible for pathologists to review tissue samples with greater accuracy than via glass slides. Digital pathology also enables new levels of collaboration, speed and automated analysis because tissue samples, once scanned and reviewed, can be easily annotated, shared, and analyzed with AI routines that help advance precision medicine.

These advantages are especially meaningful in life sciences, where organizations are under constant pressure to bring valuable innovations to market more quickly—each day sooner to market can contribute $7 million of revenue. While nearly 85% of life sciences companies have implemented a first-generation digital solution, more than half remain on platforms that hamper the use of AI solutions.

The Proscia lead-gen campaign

Proscia’s open-architecture Concentriq platform powers and integrates AI-based pathology technology, helping life sciences organizations accelerate research and speed new, life-altering treatments to market.

To connect more organizations with their platform, Proscia sought to generate leads by offering an exclusive report from respected publication In Vivo that presents new insights and research findings to pathologists and laboratory leaders. StudioNorth leveraged LinkedIn’s lead gen ads—with compelling visuals and copy—to provide a seamless process for potential leads to engage with the ads, share their contact information, and access the report within the LinkedIn interface.

We also integrated the LinkedIn campaign with Proscia’s Salesforce database so leads would automatically enter their nurture streams. LinkedIn’s advanced targeting options helped us reach the right audience at the right time, generating high-quality leads and exceeding all targeted benchmarks.